{"cord_uid": "htoexg53", "sourcedb": "PMC", "sourceid": "PMC6316859", "divid": "12", "text": "To generate high titer vaccine preparations for preclinical studies , recombinant MVA was amplified in CEF , purified by ultracentrifugation through 36 % sucrose cushions , resuspended in 10 mM Tris - HCl buffer , pH 9 . 0 , and stored at \u2212 80 \u2022 C . The sucrose purified MVA - MERS - N vaccine preparations corresponded in total protein / total DNA content to the purity profile of a MVA candidate vaccine for human use .", "project": "cdlai_CORD-19", "denotations": [{"id": 1, "span": {"begin": 154, "end": 162}, "obj": "ne"}, {"id": 2, "span": {"begin": 194, "end": 205}, "obj": "ne"}, {"id": 3, "span": {"begin": 254, "end": 262}, "obj": "ne"}, {"id": 4, "span": {"begin": 271, "end": 275}, "obj": "ne"}]}